4-Ethyl-1,2-dimethoxybenzene
Common Name: |
4-Ethyl-1,2-dimethoxybenzene |
IUPAC Name: |
4-ethyl-1,2-dimethoxybenzene |
Molecular Formula: |
C10H14O2 |
SMILES: |
CCC1=CC(=C(C=C1)OC)OC |
Inchi: |
1S/C10H14O2/c1-4-8-5-6-9(11-2)10(7-8)12-3/h5-7H,4H2,1-3H3 |
Inchi Key: |
NEBQMYHKOREVAL-UHFFFAOYSA-N |
Cas No: |
5888-51-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
166.22 |
Mass (g/mol) |
166.099 |
Molar Refractivity |
49.20 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
3 |
Rings |
1 |
TPSA |
18.46 |
Hetero Atoms |
2 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
226.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.125 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.40 |
LogP |
2.266 |
iLOGP |
2.53 |
XLOGP3 |
2.25 |
WLOGP |
2.27 |
MLOGP |
2.10 |
ESOL Log S |
-2.46 |
ESOL Solubility (mg/ml) |
0.576 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.27 |
Ali Solubility (mg/ml) |
0.89 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.44 |
Silicos-IT Solubility (mg/ml) |
0.06 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.72 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.711 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.082 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Warning |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |